36,375 Shares in Prestige Consumer Healthcare Inc. (NYSE:PBH) Bought by Kestrel Investment Management Corp

Kestrel Investment Management Corp purchased a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 36,375 shares of the company's stock, valued at approximately $2,504,000. Prestige Consumer Healthcare comprises approximately 1.7% of Kestrel Investment Management Corp's portfolio, making the stock its 29th largest position. Kestrel Investment Management Corp owned about 0.07% of Prestige Consumer Healthcare at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Opal Wealth Advisors LLC acquired a new position in shares of Prestige Consumer Healthcare during the second quarter worth approximately $26,000. Quest Partners LLC lifted its stake in shares of Prestige Consumer Healthcare by 2,826.7% during the second quarter. Quest Partners LLC now owns 439 shares of the company's stock valued at $30,000 after acquiring an additional 424 shares during the period. EverSource Wealth Advisors LLC raised its holdings in Prestige Consumer Healthcare by 80.6% during the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company's stock worth $33,000 after purchasing an additional 208 shares during the last quarter. Principal Securities Inc. bought a new position in shares of Prestige Consumer Healthcare in the 4th quarter valued at about $29,000. Finally, Gladius Capital Management LP acquired a new stake in shares of Prestige Consumer Healthcare during the 2nd quarter worth approximately $35,000. 99.95% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

PBH has been the topic of a number of recent research reports. StockNews.com cut shares of Prestige Consumer Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Tuesday, May 21st. DA Davidson lifted their price objective on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a "buy" rating in a research note on Wednesday, August 28th. Finally, Canaccord Genuity Group restated a "buy" rating and set a $80.00 target price on shares of Prestige Consumer Healthcare in a report on Tuesday, May 21st. One analyst has rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, Prestige Consumer Healthcare presently has a consensus rating of "Moderate Buy" and an average target price of $98.75.

Prestige Consumer Healthcare Stock Down 0.6 %

Shares of NYSE:PBH traded down $0.44 during trading on Monday, hitting $73.68. 174,605 shares of the company's stock traded hands, compared to its average volume of 203,273. The company has a current ratio of 3.23, a quick ratio of 1.90 and a debt-to-equity ratio of 0.65. The company has a 50-day moving average price of $70.88 and a 200-day moving average price of $69.58. Prestige Consumer Healthcare Inc. has a 52 week low of $56.34 and a 52 week high of $75.80. The company has a market cap of $3.65 billion, a price-to-earnings ratio of 17.67, a price-to-earnings-growth ratio of 2.06 and a beta of 0.48.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, beating analysts' consensus estimates of $0.86 by $0.04. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The firm had revenue of $267.10 million for the quarter, compared to analyst estimates of $260.54 million. During the same quarter in the previous year, the firm posted $1.06 earnings per share. The business's revenue was down 4.4% on a year-over-year basis. As a group, research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.42 EPS for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.